| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
251,510,000 |
| Market
Cap: |
136.22(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$414.13 - $543.89 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 17 |
| Guru Rank Value : 22.1 |
| Guru Occurances : 4 |
|
|
|
|
|
| |
|
Company Profile Elevance Health is an insurance holding company. Co. is a health benefits company, serving medical members through its affiliated health plans. Co. has four segments: Commercial and Specialty Business, which provides fully-insured health products, managed care services; Government Business, which includes Medicare and Medicaid businesses, its subsidiary, National Government Services, and services provided to the federal government in connection with its Federal Health Products and Services business; IngenioRx, which includes its pharmacy benefit management business; and Other, which includes Diversified Business Group, which is its integrated health services business.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
44,753 |
52,053 |
52,427 |
77,577 |
| Total Sell Value |
$23,062,766 |
$26,598,808 |
$26,775,666 |
$38,325,083 |
| Total People Sold |
4 |
6 |
7 |
8 |
| Total Sell Transactions |
5 |
8 |
10 |
15 |
| End Date |
2024-02-18 |
2023-11-17 |
2023-05-19 |
2022-05-19 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Tallett Elizebeth E |
Director |
• • – |
2018-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
753 |
7,061 |
|
- |
|
| Peru Ramiro G |
Director |
• • – |
2018-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
753 |
14,324 |
|
- |
|
| Hay Lewis III |
Director |
• • – |
2018-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
753 |
7,676 |
|
- |
|
| Schaefer George A Jr |
Director |
• • – |
2018-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
753 |
38,864 |
|
- |
|
| Hill Julie A |
Director |
• • – |
2018-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
753 |
36,075 |
|
- |
|
| Neri Antonio F |
Director |
• • – |
2018-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
753 |
1,094 |
|
- |
|
| Clark R Kerry |
Director |
• • – |
2018-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
753 |
5,809 |
|
- |
|
| Griffin Brian T |
EVP & CEO, IngenioRx |
• • – |
2018-05-03 |
4 |
S |
$224.32 |
$13,334,390 |
D/D |
(59,421) |
15,863 |
|
- |
|
| Griffin Brian T |
EVP & CEO, IngenioRx |
• • – |
2018-05-03 |
4 |
OE |
$61.88 |
$6,961,995 |
D/D |
59,421 |
75,284 |
|
- |
|
| Mccarthy Gloria M |
EVP & Chief Administrative Off |
• • – |
2018-04-03 |
4 |
D |
$227.51 |
$41,862 |
D/D |
(184) |
38,840 |
|
- |
|
| Zielinski Thomas C |
EVP & General Counsel |
• • – |
2018-03-13 |
4 |
S |
$228.98 |
$4,688,870 |
D/D |
(20,455) |
26,084 |
|
- |
|
| Zielinski Thomas C |
EVP & General Counsel |
• • – |
2018-03-13 |
4 |
OE |
$108.35 |
$2,889,673 |
D/D |
20,455 |
46,539 |
|
- |
|
| Penczek Ronald W |
SVP, Chief Accounting Officer |
• • – |
2018-03-07 |
4 |
S |
$231.82 |
$455,925 |
D/D |
(1,966) |
928 |
|
- |
|
| Penczek Ronald W |
SVP, Chief Accounting Officer |
• • – |
2018-03-07 |
4 |
OE |
$131.80 |
$144,871 |
D/D |
979 |
2,894 |
|
- |
|
| Swedish Joseph |
Executive Chairman |
• • – |
2018-03-05 |
4 |
AS |
$229.21 |
$6,435,756 |
D/D |
(27,846) |
61,419 |
|
- |
|
| Gallina John E |
EVP & Chief Financial Officer |
• • – |
2018-03-05 |
4 |
AS |
$229.19 |
$5,647,898 |
D/D |
(24,576) |
15,934 |
|
- |
|
| Gallina John E |
EVP & Chief Financial Officer |
• • – |
2018-03-05 |
4 |
OE |
$61.88 |
$1,874,219 |
D/D |
18,371 |
40,510 |
|
- |
|
| Gallina John E |
EVP & Chief Financial Officer |
• • – |
2018-03-05 |
4 |
GD |
$0.00 |
$0 |
D/D |
2,448 |
22,139 |
|
- |
|
| Swedish Joseph |
Executive Chairman |
• • – |
2018-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
56,519 |
89,265 |
|
- |
|
| Swedish Joseph |
Executive Chairman |
• • – |
2018-03-02 |
4 |
D |
$233.08 |
$6,456,549 |
D/D |
(27,701) |
32,746 |
|
- |
|
| Gallina John E |
EVP & Chief Financial Officer |
• • – |
2018-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
4,211 |
24,587 |
|
- |
|
| Gallina John E |
EVP & Chief Financial Officer |
• • – |
2018-03-02 |
4 |
D |
$233.08 |
$393,439 |
D/D |
(1,688) |
20,376 |
|
- |
|
| Zielinski Thomas C |
EVP & General Counsel |
• • – |
2018-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
12,228 |
26,084 |
|
- |
|
| Zielinski Thomas C |
EVP & General Counsel |
• • – |
2018-03-02 |
4 |
D |
$233.08 |
$1,277,745 |
D/D |
(5,482) |
13,856 |
|
- |
|
| Haytaian Peter D |
EVP & President, GBD |
• • – |
2018-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
16,304 |
60,206 |
|
- |
|
1950 Records found
|
|
Page 14 of 78 |
|
|
6.09 (1.11%) 
